Markus Zojer
Impact in
- Molecular Medicine top 10%
- Antibiotic Resistance in Bacteria
-
- Cancer Cells and Metastasis
- Cancer-related Molecular Pathways
Papers in
-
- Protein Degradation and Inhibitors 2
- Gut microbiota and health 2
- Genetics 6
- Chronic Lymphocytic Leukemia Research 5
- Evolution and Genetic Dynamics 2
- Co-authors
- Thomas Rattei (4 shared papers)Christine Moissl‐Eichinger (1 shared paper)David Bogumil (1 shared paper)Gabriele Berg (1 shared paper)Itzhak Mizrahi (1 shared paper)José Luis Martínez (1 shared paper)Alexander Mahnert (1 shared paper)Heidemarie Huber (1 shared paper)
- Partner nations
- AustriaSpainUnited States
In The Last Decade
Markus Zojer
13 papers receiving 470 citations
Peers
Comparison fields: 5 of 82
- Molecular Medicine 36
- Oncology 131
- Applied Microbiology and Biotechnology 9
- Hepatology 31
- Pollution 49
Countries citing papers authored by Markus Zojer
This map shows the geographic impact of Markus Zojer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Zojer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Zojer more than expected).
Fields of papers citing papers by Markus Zojer
This network shows the impact of papers produced by Markus Zojer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Zojer. The network helps show where Markus Zojer may publish in the future.
Co-authors
The 25 scholars most cited alongside Markus Zojer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 178 | |
| 2 | 2019 | 148 | |
| 3 | 2019 | 39 | |
| 4 | 2019 | 30 | |
| 5 | 2020 | 17 | |
| 6 | 2018 | 15 | |
| 7 | 2017 | 13 | |
| 8 | 2022 | 10 | |
| 9 | 2020 | 8 | |
| 10 | 2024 | 8 | |
| 11 | 2020 | 7 | |
| 12 | 2025 | 3 | |
| 13 | 2023 | 2 | |
| 14 | 2024 | 0 |
About Markus Zojer
Markus Zojer is a scholar working on Molecular Biology, Genetics, Hematology, Pulmonary and Respiratory Medicine and Genetics, having authored 14 papers that have together received 478 indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (5 papers), Advanced Breast Cancer Therapies (3 papers), Acute Myeloid Leukemia Research (3 papers), Protein Degradation and Inhibitors (2 papers), Hematopoietic Stem Cell Transplantation (2 papers), Gut microbiota and health (2 papers), Evolution and Genetic Dynamics (2 papers) and Insect symbiosis and bacterial influences (2 papers). The work is most often cited by research in Molecular Medicine (36 citations), Oncology (131 citations), Applied Microbiology and Biotechnology (9 citations), Hepatology (31 citations) and Pollution (49 citations). Markus Zojer has collaborated with scholars based in Austria, Spain and United States. Frequent co-authors include Thomas Rattei, Christine Moissl‐Eichinger, David Bogumil, Gabriele Berg, Itzhak Mizrahi, José Luis Martínez, Alexander Mahnert, Heidemarie Huber, Hartmut Beug and Andreas Weith. Their work appears in journals such as Blood, iScience, Oncogene, PeerJ and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.